Immunotherapy of primary liver cancer. A control study of 51 patients.
dc.contributor.author | Plengvanit, U | en_US |
dc.contributor.author | Chearanai, O | en_US |
dc.contributor.author | Asavanich, C | en_US |
dc.contributor.author | Rungpitarangsi, B | en_US |
dc.contributor.author | Yongchaiyud, U | en_US |
dc.contributor.author | Viranuvatti, V | en_US |
dc.date.accessioned | 2009-05-27T18:42:07Z | |
dc.date.available | 2009-05-27T18:42:07Z | |
dc.date.issued | 1986-02-01 | en_US |
dc.description | Chotmaihet Thangphaet. | en_US |
dc.identifier.citation | Plengvanit U, Chearanai O, Asavanich C, Rungpitarangsi B, Yongchaiyud U, Viranuvatti V. Immunotherapy of primary liver cancer. A control study of 51 patients. Journal of the Medical Association of Thailand. 1986 Feb; 69(2): 59-64 | en_US |
dc.identifier.uri | https://imsear.searo.who.int/handle/123456789/39675 | |
dc.language.iso | eng | en_US |
dc.source.uri | https://www.mat.or.th/journal/all.php | en_US |
dc.subject.mesh | Adenoma, Bile Duct --drug therapy | en_US |
dc.subject.mesh | Adult | en_US |
dc.subject.mesh | Bile Duct Neoplasms --drug therapy | en_US |
dc.subject.mesh | Carcinoma, Hepatocellular --drug therapy | en_US |
dc.subject.mesh | Female | en_US |
dc.subject.mesh | Humans | en_US |
dc.subject.mesh | Levamisole --therapeutic use | en_US |
dc.subject.mesh | Liver Neoplasms --drug therapy | en_US |
dc.subject.mesh | Male | en_US |
dc.subject.mesh | Middle Aged | en_US |
dc.title | Immunotherapy of primary liver cancer. A control study of 51 patients. | en_US |
dc.type | Journal Article | en_US |
Files
License bundle
1 - 1 of 1